Jeannine M. Rivet serves as Independent Director of the Company. Ms. Rivet served as Executive Vice President of UnitedHealth Group from 2001 until her retirement in December 2018. Previously, she served as Chief Executive Officer of UnitedHealthcare from 1998 to 2001, Chief Executive Officer of Ingenix from 2001 to 2003 and Chief Executive Officer of Optum from December 2003 to 2005. Ms. Rivet received her Bachelor of Science in Nursing from Boston College and her Master’s Degree in Public Health from Boston University. She also worked as a registered nurse for several years prior to entering the managed care business.
As the Independent Director of Abiomed, the total compensation of Jeannine Rivet at Abiomed is $267,496. There are 12 executives at Abiomed getting paid more, with Michael Minogue having the highest compensation of $16,612,800.
Jeannine Rivet is 72, she's been the Independent Director of Abiomed since 2016. There are no older and 17 younger executives at Abiomed.
Jeannine's mailing address filed with the SEC is C/O ABIOMED, INC, 22 CHERRY HILL DR, DANVERS, MA, 01923.
Over the last 21 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose und David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: